These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9721229)

  • 1. Mapping of a neurovirulence determinant within the envelope protein of a polytropic murine retrovirus: induction of central nervous system disease by low levels of virus.
    Poulsen DJ; Robertson SJ; Favara CA; Portis JL; Chesebro BW
    Virology; 1998 Sep; 248(2):199-207. PubMed ID: 9721229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reexamination of amphotropic murine leukemia virus neurovirulence: neural stem cell-mediated microglial infection fails to induce acute neurodegeneration.
    Traister RS; Lynch WP
    Virology; 2002 Feb; 293(2):262-72. PubMed ID: 11886246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased neurovirulence of polytropic mouse retroviruses delivered by inoculation of brain with infected neural stem cells.
    Poulsen DJ; Favara C; Snyder EY; Portis J; Chesebro B
    Virology; 1999 Oct; 263(1):23-9. PubMed ID: 10544079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurovirulence of polytropic murine retrovirus is influenced by two separate regions on opposite sides of the envelope protein receptor binding domain.
    Peterson KE; Pourciau S; Du M; Lacasse R; Pathmajeyan M; Poulsen D; Agbandje-McKenna M; Wehrly K; Chesebro B
    J Virol; 2008 Sep; 82(17):8906-10. PubMed ID: 18579597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurologic disease induced by polytropic murine retroviruses: neurovirulence determined by efficiency of spread to microglial cells.
    Robertson SJ; Hasenkrug KJ; Chesebro B; Portis JL
    J Virol; 1997 Jul; 71(7):5287-94. PubMed ID: 9188597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glycosylated gag protein of MuLV is a determinant of neuroinvasiveness: analysis of second site revertants of a mutant MuLV lacking expression of this protein.
    Portis JL; Fujisawa R; Mcatee FJ
    Virology; 1996 Dec; 226(2):384-92. PubMed ID: 8955058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a neurologic disease induced by a polytropic murine retrovirus: evidence for differential targeting of ecotropic and polytropic viruses in the brain.
    Portis JL; Czub S; Robertson S; McAtee F; Chesebro B
    J Virol; 1995 Dec; 69(12):8070-5. PubMed ID: 7494324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic analysis of spongiform neurodegenerative disease induced by a highly virulent murine retrovirus.
    Czub S; Lynch WP; Czub M; Portis JL
    Lab Invest; 1994 May; 70(5):711-23. PubMed ID: 8196367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased proinflammatory cytokine and chemokine responses and microglial infection following inoculation with neural stem cells infected with polytropic murine retroviruses.
    Peterson KE; Evans LH; Wehrly K; Chesebro B
    Virology; 2006 Oct; 354(1):143-53. PubMed ID: 16875710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in cytokine and chemokine responses during neurological disease induced by polytropic murine retroviruses Map to separate regions of the viral envelope gene.
    Peterson KE; Robertson SJ; Portis JL; Chesebro B
    J Virol; 2001 Mar; 75(6):2848-56. PubMed ID: 11222710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoprotective determinants in friend murine leukemia virus envelope protein.
    Hasenkrug KJ; Brooks DM; Robertson MN; Srinivas RV; Chesebro B
    Virology; 1998 Aug; 248(1):66-73. PubMed ID: 9705256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two separate envelope regions influence induction of brain disease by a polytropic murine retrovirus (FMCF98).
    Hasenkrug KJ; Robertson SJ; Porti J; McAtee F; Nishio J; Chesebro B
    J Virol; 1996 Jul; 70(7):4825-8. PubMed ID: 8676516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
    Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
    Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell types in the central nervous system infected by murine retroviruses: implications for the mechanisms of neurodegeneration.
    Wong PK; Yuen PH
    Histol Histopathol; 1994 Oct; 9(4):845-58. PubMed ID: 7894152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique sequence and lesional tropism of a new variant of neuropathogenic friend murine leukemia virus.
    Takase-Yoden S; Watanabe R
    Virology; 1997 Jul; 233(2):411-22. PubMed ID: 9217064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance.
    Kozak CA; Chakraborti A
    Virology; 1996 Nov; 225(2):300-5. PubMed ID: 8918916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparate regions of envelope protein regulate syncytium formation versus spongiform encephalopathy in neurological disease induced by murine leukemia virus TR.
    Murphy SL; Honczarenko MJ; Dugger NV; Hoffman PM; Gaulton GN
    J Virol; 2004 Aug; 78(15):8392-9. PubMed ID: 15254211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separate sequences in a murine retroviral envelope protein mediate neuropathogenesis by complementary mechanisms with differing requirements for tumor necrosis factor alpha.
    Peterson KE; Hughes S; Dimcheff DE; Wehrly K; Chesebro B
    J Virol; 2004 Dec; 78(23):13104-12. PubMed ID: 15542662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The drug monosodium luminol (GVT) preserves crypt-villus epithelial organization and allows survival of intestinal T cells in mice infected with the ts1 retrovirus.
    Scofield VL; Yan M; Kuang X; Kim SJ; Wong PK
    Immunol Lett; 2009 Feb; 122(2):150-8. PubMed ID: 19186189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancer mutations of Akv murine leukemia virus inhibit the induction of mature B-cell lymphomas and shift disease specificity towards the more differentiated plasma cell stage.
    Sørensen KD; Kunder S; Quintanilla-Martinez L; Sørensen J; Schmidt J; Pedersen FS
    Virology; 2007 May; 362(1):179-91. PubMed ID: 17258785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.